Filing Details
- Accession Number:
- 0001127602-22-011678
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-06 17:02:51
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-06 17:02:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1844305 | P Daniel Finke | One Cvs Drive Woonsocket RI 02895 | Evp/Pres, Health Care Benefits | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-04 | 16,161 | $54.19 | 66,284 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-04 | 16,161 | $100.13 | 50,123 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-04-04 | 27,166 | $58.34 | 77,289 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-04 | 27,166 | $100.13 | 50,123 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-04 | 12,032 | $100.13 | 38,091 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-05 | 5,941 | $100.00 | 32,150 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2022-04-04 | 16,161 | $0.00 | 16,161 | $54.19 |
Common Stock | Stock Option | Disposition | 2022-04-04 | 27,166 | $0.00 | 27,166 | $58.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,161 | 2020-04-01 | 2029-04-01 | No | 4 | M | Direct |
27,166 | 2021-04-01 | 2030-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock (Pep) | 3,098 | Direct | |
Common Stock (Restricted) | 15,904 | Direct | |
Stock Unit (Deferred) | 3,098 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $74.30 | 2022-04-01 | 2031-04-01 | 82,066 | 82,066 | Direct |
Common Stock | Stock Option | $52.37 | 2022-05-31 | 2029-05-31 | 28,640 | 28,640 | Direct |
Common Stock | Stock Option | $101.09 | 2023-04-01 | 2032-04-01 | 51,975 | 51,975 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-04-01 | 82,066 | 82,066 | Direct |
2029-05-31 | 28,640 | 28,640 | Direct |
2032-04-01 | 51,975 | 51,975 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Option became exercisable in four equal annual installments, beginning on 4/1/2020.
- Option became exercisable in four equal annual installments, commencing 4/1/2021.
- Option becomes exercisable in four equal installments, commencing 4/1/2022.
- Option becomes exercisable in three equal installments, commencing 5/31/2022.
- Option becomes exercisable in four equal installments, commencing 4/1/2023.